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Herein is reported a concise synthesis of spiro-annulated cyclobutane tetracyclic and pentacyclic derivatives by ketene 
addition, and ring-rearrangement metathesis (RRM) as key steps, starting with commercially available norbornadiene and 
dicyclopentadiene. The tetracyclic spiro-derivative contains a [5/5/4] core unit, which is the key building block to angular 
triquinanes synthesis. Whereas, the pentacyclic spiro-derivative contains a basic core skeleton of presilphiperfolanes, and 
other sesquiterpenoids. 
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Most of the natural products such as alkaloids, 
terpenoids, lactones, etc. contain spirocyclics as a core 
units. Due to their intrinsic rigidity and complexity, 
spirocycles draw increasing attention in modern drug 
design and also in medicinal chemistry
1,2
. Cyclobutane is 
a highly strained ring system, commonly present in 
natural products. However, cyclobutane containing 
spirocyclic compounds are present in limited number of 
natural products, for example phainanoids, phainanoid F 
1, licopodine derivative 2. The cyclobutane compound 3 
is a highly potent inhibitor of histone methyltransferase. 
Whereas, the hydroxyl derivatives 4 and 5 are BACE1 
(β-site APP-cleaving enzyme 1) inhibitors that lower 




Here, we described the synthesis of a rare class of 
spiro-annulated cyclobutane derivatives by in 





 in a concise manner. 
These derivatives can be useful building blocks to 
angular triquinanes6, sesquiterpenoids, and 
presilphiperfolane type of compounds. 
 
Results and Discussion 
Our synthesis starts with ketene addition to 
norbornadiene 6 which involve the reaction of 
trichloroacetyl chloride in the presence of zinc metal in 
anhydrous ether at RT for overnight to deliver the 
[2+2] cycloaddition product 7 in 68% yield
7
. The 
dichloro compound 7 was exposed to allylation using 
NaHMDS and LiHMDS and we found that by using 
LiHMDS condition gave the allylation product to 
generate the compound 8 in 57% yield8. Subsequently, 
metathesis of the compound 8 using G-I catalyst in 
CH2Cl2 at RT gave ring-opening metathesis (ROM) 
conditions product 9 in 52% yield (Scheme I). 
 
Thereafter, the ROM derivative 9 was subjected to 
ring-closing metathesis (RCM)
9
 using various 
conditions by changing the catalysts (G-I, G-II, HG-I 
and HG-II), catalyst loading (5 mol% and 10 mol%), 
solvent (CH2Cl2, PhMe) and temperature (RT to reflux 
temperature). However, we failed to get the desired 
RCM product 10
3a
. This may be because of steric 
factor associated with chlorine atoms present or 
unfavourable stereochemistry of the unsaturated double 
bonds present in the compound 9. 
 
Thereafter, the compound 11 was subjected to 
dechlorination using Zn/AcOH at 80°C, gave the 
cyclobutanone derivative 12 in good yield
10
. Using 
NaHMDS or LiHMDS as a base, the compound 12 was 
reacted with 4.0 equiv. of allyl bromide at −78°C, and 
obtained the triallyl derivative 13 in good yield. Finally, 
the triallyl compound 13 was subjected to metathesis 
with G-I catalyst (5 mol%) to deliver the spiro-tricylic 
derivative 14 via ring-rearrangment metathesis (RRM) 
and RCM in a moderate yields (Scheme II). Later, we 
have optimized the reaction conditions (Table I) to 
obtain better yields of metathesis product 14
11
. The spiro 
compound 14 has a [5/5/4] tricyclic core. Compounds 
containing [5/5/4] tricyclic unit were synthetically 
transformed to angular triquinanes (e.g. ventricosene
12a
) 
by ring expansion of cyclobutane
12
. 




Additionally, the allyl derivative 8 was treated with 
allyl Grignard reagent at 0°C to synthesize the 
compound 15 in 78% yields
13
. Subsequent metathesis 
of 15 by using G-I catalyst, produced the [5/4/6] 
tricyclic derivative 16 in 75% yield (Scheme III). 
 
Thereafter, we expanded this strategy to synthesize a 
new class of spiro-compound using dicyclopentadiene 
17 as a starting material using ketene addition. First, 
the dicyclopentadiene 17 was treated with 
trichloroacetyl chloride in a suspension of Zn in AcOH 
to deliver a mixture of ketene addition products 18a 
and 18b in 57% and 25% respectively
7
. Upon 
dechlorination by using Zn/AcOH method the 
compound 18a, delivered the dechlorinated compound 
19 in 80% yield
9
. Further, this compound 19 was 
subjected to allylation by using 4.0 equiv. of allyl 
bromide in the presence of NaHMDS as a base at 
−78°C8, to produce the triallyl derivative 20, which 
was subjected to metathesis to yield the spiro-annulated 
pentacyclic compound 21 in 82% yields (Scheme IV). 
This pentacyclic compound 21 containing spiro 
unit has a [5/5/4] tricyclic scaffold and [5/6/5] 
tricyclic scaffold. Interestingly, [5/5/4] tricyclic unit is 





Figure 1 — Cyclobutane containing spirocyclic natural products 
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Scheme II — Synthesis of the spirocyclic compound 14 
 




Solvent Temp. (°C) Time (h) Yield of 14 
1 G-I (5) CH2Cl2 RT 8 79 
2 G-I (10) CH2Cl2 RT 6 83 
3 G-II (5) CH2Cl2 RT 6 80 
4 G-II (10) CH2Cl2 RT 4 82 
5 G-I (5) PhMe 80 4 68 
6 G-II (5) PhMe 80 4 70 
 




such as repraesentin F, kelsoene, (+)-sulcatine G and 
poduran. While, the [5/6/5] tricyclic unit is a core 




Materials and Methods 
All commercially available reagents were used 
without further purification and the reactions 
involving air-sensitive catalysts or reagents were 
performed in degassed solvents. Grubbs (G-I, G-II) 
and Grubbs-Hoveyda (GH-I, GH-II) catalysts were 
purchased from Aldrich Chemical Company. All 
metathesis reactions were carried out under ethylene 
atmosphere. The 
1
H NMR (400 and 500 MHz) 
chemical shifts were reported in parts per million (δ) 
relative to internal solvent signal (δ 7.26 in CDCl3) 
and the coupling constants J are reported in Hertz 
(Hz). The 
13
C NMR (100 and 125 MHz) chemical 
shifts were referenced to the internal solvent signals 
(central peak is δ 77.16 in CDCl3). The high-
resolution mass spectrometric (HRMS) measurements 
were carried out using a Bruker (Maxis Impact) or 
Micromass Q-ToF spectrometer. Infrared (IR) spectra 
were recorded on Nicolet Impact-400 FT-IR 





Synthesis of the allyl derivative 13 
To the solution of the compound 12 (200mg, 1 
mmol) in dry THF, 1M solution of LiHMDS (4.0 eq) 
in THF was added and stirred for 15 min at −78°C. 
Later, allyl bromide (0.22 mL, 2.5 eq.) was added 
 
 








Figure 2 — Natural products containing [5/5/4] tricyclic core and [5/5/6] tricyclic core 
 




drop-wise at −78°C, and the reaction mixture was 
stirred at the same temperature for 1 h. Further, the 
reaction mixture brought back to RT slowly in 8 h. 
After completion of reaction, it was quenched with 
H2O and extracted with ethylacetate (3 × 30 mL). The 
combined organic layer was washed with H2O, dried 
over Na2SO4 and concentrated to get the crude 
compound 13 which was purified by column 
chromatography. Yield 57% (136 mg), colourless 
liquid, Rf = 0.75 (2% EtOAc/hexane). IR (neat): 2931, 




H NMR (CDCl3, 400 MHz): δ 6.50 (dd, 1H), 6.33 
(dd, 1H), 5.92‒5.80 (m, 1H), 5.28‒5.18 (m, 2H), 3.19 
(s, 1H), 2.90‒2.73 (m, 2H), 2.48 (t, 1.46 Hz, 1H), 1.95 
(d, J = 10.68 Hz, 1H), 1.65 (qd, J = 14.36 Hz, 1.84 
Hz, 1H); 
13
C NMR (CDCl3, 100 MHz): δ 200.4, 
140.6, 137.1, 130.3, 120.8, 82.4, 71.4, 56.2, 49.6, 
46.3, 44.44, 44.41. 
 
General procedure for dechlorination 
The chloro compound (11 or 18a, 0.5 mmol,  
1 equiv) was dissolved in glac. AcOH (0.2 mL) and 
added to the suspension of Zn in AcOH (1.0 mL) and 
the resulting mixture was heated to 80°C for 5 h. 
After completion of reaction, the reaction mixture was 
brought to RT and quenched with H2O. Compound 
was extracted with Et2O (3 × 40 mL) from the 
aqueous reaction mixture. The combined ether layer 
was washed with H2O (2 × 30 mL), dried over 
Na2SO4 and evaporated to dry. The crude product was 
purified by column chromatography to get the desired 
dechloro compound as a colourless liquid. 
12: Yield 72% (240 mg), from 500 mg of 11, 
Colorless liquid. Rf = 0.85 (2% EtOAc/hexane). 
1H NMR (CDCl3, 400 MHz): δ 6.23 (dd, J = 5.63 Hz, 
1H), 6.06 (dd, J = 6.62 Hz, 3.32 Hz, 1H), 2.98 (brs, 
1H), 2.94 (brs, 1H), 2.83‒2.72 (m, 1H), 2.29‒2.19 (m, 
2H), 1.48 (d, J = 1.48 Hz, 2H), 1.34‒1.32 (m, 1H), 
1.14 (t, J = 7.02 Hz, 1H); 
13
C NMR (CDCl3, 100 
MHz): δ 211.5, 139.7, 136.0, 66.1, 45.5, 44.0, 43.0, 
40.9, 30.1. 
19: Yield 80% (265 mg), from 500 mg of 18a, 
Colorless liquid. Rf = 0.85 (2% EtOAc/hexane). IR 




H NMR (CDCl3, 400 MHz): δ 6.17 (s, 2H), 2.91 (d, 
1H, J = 3.46 Hz), 2.66 (s, 1H), 2.62 (d, 1H, J = 16.56 
Hz), 2.48 (d, 1H, J = 3.47 Hz) 2.17 (s, 2H), 1.54 (ABq, 
1H, J = 39.18 Hz, 9.45 Hz), 1.44 (s, 1H); 
13
C NMR 
(CDCl3, 100 MHz): δ 211.5, 139.7, 136.0, 66.1, 45.5, 
44.0, 43.0, 40.9, 30.1; HRMS (ESI, Q-ToF): m/z [M + 
H]+ Calcd for C12H15O: 175.1123. Found: 175.1120. 
General procedure of triallylation 
To the solution of the keto compound 12 or 19 (1 eq) 
in dry THF, 1M solution of NaHMDS (4.0 eq) in THF 
was added and stirred for 15 min at −78°C. Later, allyl 
bromide (4.0 eq.) was added drop-wise at −78°C and the 
reaction mixture was stirred at the same temperature for 
1 h. Further, the reaction mixture brought back to RT 
slowly in 8 h. After completion of reaction, it was 
quenched with H2O and extracted with ethylacetate  
(3 × 30 mL). The combined organic layer was washed 
with H2O, dried over Na2SO4 and concentrated to get the 
crude triallyl compound (13 or 20) which was purified 
by column chromatography using 2% EtOAc/ hexane. 
13: Yield 78% (220 mg from 150 mg of 12) as a 
colorless liquid. Rf = 0.85 (2% EtOAc/hexane). IR 





H NMR (CDCl3, 400 MHz): δ 5.95‒5.72 (m, 
3H), 5.30‒4.98 (m, 6H), 3.23‒2.78 (m, 5H), 2.26‒2.17 
(m, 1H), 2.03‒1.98 (m, 1H). 14.36 Hz, 1.84 Hz, 1H); 
13
C NMR (CDCl3, 100 MHz): δ 200.1, 139.8, 135.3, 
130.3, 120.9, 118.1, 115.4, 60.7, 51.2, 45.8, 43.8, 40.4; 
HRMS (ESI, Q-ToF): m/z [M + Na]
+
 Calcd for 
C18H22ONa: 277.1563. Found: 277.1567. 
20: Yield 70% (200 mg from 150 mg of 19) as a 
colorless liquid. Rf = 0.85 (2% EtOAc/hexane). IR 




H NMR (CDCl3, 500 MHz): δ 6.22 (s, 2H), 5.93-5.81 
(m, 2H), 5.74-5.63 (m, 1H), 5.17-5.08 (m, 6H), 2.99 (s, 
1H), 2.89 (dd, 1H, J = 9.70 Hz, 3.60 Hz), 2.80 (s, 1H), 
2.66 (t, 2H, J = 6.64 Hz), 2.50 (d, 1H, J = 8.88 Hz), 
2.33-2.25 (m, 3H), 2.20 (dd, 1H, J = 14.36 Hz, 2.21 
Hz), 1.78 (dd, 1H, J = 14.53 Hz, 9.22 Hz), 1.72-1.67 (m, 
2H), 1.63 (d, 1H, J = 8.09 Hz), 1.48-1.43 (m, 1H), 1.38 
(td, 1H, J = 14.44 Hz, 7.28 Hz); 
13
C NMR (CDCl3, 125 
MHz): δ 220.7 (C), 142.6 (CH), 136.4 (CH), 135.7 
(CH), 128.5 (CH), 128.3 (CH), 125.7 (CH), 118.4 
(CH2), 117.8 (CH2), 117.5 (CH2), 71.9 (C), 62.5 (C), 
55.5 (CH), 54.2 (CH2), 51.2 (CH), 51.0 (CH), 46.5 
(CH), 46.1 (CH), 35.9 (CH2), 34.4 (CH2), 31.2 (CH2), 
29.4 (CH2); HRMS (ESI, Q-ToF): m/z [M + Na]
+
 Calcd 
for C21H26ONa: 317.1876. Found: 317.1873. 
 
Synthesis of compound 15 
The compound 8 (150 mg, 0.62 mmol) was 
dissolved in dry THF under N2 atmosphere and cooled 
to 0°C. To this 1 M allyl Grignard solution (1.2 mL, 2 
eq) in THF was added at 0°C and allowed to stir for 4 h 
at RT under N2 atmosphere. After completion of 
reaction by TLC monitoring, the reaction mixture was 
quenched with Sat. NH4Cl solution, extracted with 
EtOAc (3 × 30 mL). The combined organic layer was 




washed with H2O (2 × 20 mL), dried over Na2SO4 and 
concentrated to give the crude product 15 which was 
purified by column chromatography using 2% EtOAc/ 
hexane. 
 
Yield 78% (137 mg), colourless liquid. Rf = 0.75 
(2% EtOAc/hexane). IR (neat): 3331, 2936, 2410, 




H NMR (CDCl3, 400 MHz): δ 
6.33 (dd, 1H, J = 5.68 Hz, 3.12 Hz), 6.28 (dd, 1H,  
J = 5.60 Hz, 3.00 Hz), 6.19-6.04 (m, 2H), 5.38-5.00 
(m, 4H), 3.22 (s, 1H), 2.97 (brs, 1H), 2.88-2.80 (m, 
3H), 2.74 (d, 1H, J = 1.96 Hz), 1.79 (d, 1H, J = 9.84 
Hz), 1.59 (qd, 1H, J = 9.84 Hz, 1.78 Hz); 
13
C NMR 
(CDCl3, 100 MHz): δ 138.6 (CH), 136.6 (CH), 133.2 
(CH), 132.0 (C), 122.0 (CH2), 84.2 (C), 82.2 (C), 64.7 
(CH), 51.8 (CH), 45.7 (CH2), 44.3 (CH), 43.8 (CH2); 
HRMS (ESI, Q-ToF): m/z [M + Na]
+
 Calcd for 
C15H18OCl2Na: 307.0632. Found: 307.0635. 
 
General procedure for metathesis. The 
compound (13, or 15, or 20, 0.2 mmol) was dissolved 
in CH2Cl2 (7 mM) and degassed with N2 gas followed 
by ethylene for about 20 min. To this, the Grubbs 
catalyst (as mentioned in Table I, 5 mol%) catalyst 
was added and stirred at RT under ethylene 
atmosphere. The solvent was removed and the crude 
product was purified by column chromatography to 
obtain the pure product. 
 
14: Yield 83% (optimized yield (Table I), 44 mg 
from 60 mg of 13) as a colorless liquid. Rf = 0.80 (2% 
EtOAc/hexane). IR (neat): 2936, 2435, 1773, 1455, 




H NMR (CDCl3, 400 MHz):  
δ 5.90-5.78 (m, 1H), 5.70-5.58 (m, 2H), 5.55-5.49  
(m, 2H), 4.98 (td, 1H, J = 17.08 Hz, 1.32 Hz), 4.89 
(td, 1H, J = 10.23 Hz, 1.24 Hz), 3.46-3.38 (m, 1H), 
2.92-2.78 (m, 2H), 2.73-2.47 (m, 5H), 2.32 (d, 1H,  
J = 3.88 Hz), 2.20 (td, 1H, J = 13.14 Hz, 6.60 Hz), 
1.67 (td, 1H, J = 13.10 Hz, 1.65 Hz). 1.58 (s, 1H); 
13
C NMR (CDCl3, 100 MHz): δ 221.0 (C), 142.4 
(CH), 133.9 (CH), 129.1 (CH), 128.2 (CH), 127.6 (C), 
113.4 (CH2), 66.3 (C), 58.4 (CH), 56.5 (CH), 47.7 
(CH), 44.3 (CH2), 40.7 (CH2), 40.5 (CH2), 35.5 
(CH2); HRMS (ESI, Q-ToF): m/z [M + Na]
+
 Calcd for 
C16H18ONa: 249.1255. Found: 249.1258. 
 
21: Yield 82% (44 mg from 60 mg of 20) as a 
colorless liquid. Rf = 0.80 (2% EtOAc/hexane). IR 




H NMR (CDCl3, 500 MHz): δ 6.08-5.66 (m, 4H), 
5.15-4.90 (m, 4H), 3.24-3.13 (m, 2H), 2.96 (s, 1H), 
2.91 (dd, 1H, J = 15.53 Hz, 7.01 Hz), 2.59-2.56 (m, 
1H), 2.43 (d, 1H, J = 4.25 Hz), 2.26-2.19 (m, 1H), 
2.07-2.00 (m, 1H), 1.82-1.73 (m, 1H); 
13
C NMR 
(CDCl3, 125 MHz): δ 141.6 (CH), 140.6 (CH), 136.7 
(CH), 129.0 (CH), 126.4 (CH), 116.5 (CH2), 114.1 
(CH2), 78.9 (C), 60.1 (CH), 51.7 (CH), 45.0 (CH2), 
41.2 (C), 39.2 (CH2), 38.1 (CH2), 34.7 (CH2); HRMS 
(ESI, Q-ToF): m/z [M + Na]
+
 Calcd for 
C15H18OCl2Na: 307.0632. Found: 307.0633. 
16: Yield 75% (30 mg from 40 mg of 15) as a 
colorless liquid. Rf = 0.80 (2% EtOAc/hexane). IR 




H NMR (CDCl3, 400 MHz): δ 5.86-5.72 (m, 2H), 
5.71-5.65 (m, 1H), 5.64-5.53 (m, 2H), 5.03 (td, 1H,  
J = 17.16 Hz, 1.56 Hz), 4.97 (td, 1H, J = 10.33 Hz, 
1.34 Hz), 2.84 (td, 1H, J = 16.86 Hz, 2.10 Hz), 2.68 
(dd, 2H, J = 11.46 Hz, 6.64 Hz), 2.63-2.47 (m, 4H), 
2.41 (td, 1H, J = 17.11 Hz, 2.04 Hz), 2.37-2.29 (m, 
2H), 2.10-1.99 (m, 1H), 1.69 (dd, 1H, J = 14.16 Hz, 
7.04 Hz), 1.39 (d, 1H, J = 10.56 Hz), 1.54-1.47 (m, 
2H); 
13
C NMR (CDCl3, 100 MHz): δ 224.6 (C), 139.5 
(CH), 133.2 (CH), 129.0 (CH), 128.0 (CH), 121.9 
(CH), 114.6 (CH2), 77.3 (CH), 70.2 (C), 65.7 (C), 
53.2 (CH), 50.8 (CH), 48.1 (CH), 45.8 (CH), 45.4 
(CH2), 36.2 (CH2), 35.7 (CH2), 35.3 (CH), 29.4 (CH2), 
27.2 (CH2); HRMS (ESI, Q-ToF): m/z [M + Na]
+
 
Calcd for C19H22ONa: 289.1563. 
 
Conclusion 
Cyclobutane containing spiro compounds are rare 
class of spiro compounds, and a limited number of 
natural products are present. Here, we have 
synthesized [5/5/4] spiro-compound 14 and [5/6/5/4] 
spiro compound 21 starting with commercially 
available norbornadiene and dicyclopentadiene 
respectively via ketene addition, dechlorination 
followed by triallylation and metathesis sequence in 
good yields. Additionally, we have also synthesized 
[5/4/6] tricyclic derivative 16 by Grignard addition 
followed by metathesis. The core structures of these 
derivatives are present in natural products and 
bioactive compounds. This methodology has a 
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